Company Overview
Snapshot
Founded in July 2020 by Oron Zachar, Airtonics Health operates with 1–10 employees. The company is currently in a Pre-Funding stage. In May 2020, ITP-System announced its partnership in an international research project on COVID-19 therapy using nanosilver, a core focus for Airtonics Health.
Business overview
Airtonics Health specializes in developing a minimally invasive method for inactivating the SARS-CoV-2 coronavirus at an early stage of infection. The company's core technology utilizes nanosilver with specific physicochemical parameters to achieve this therapeutic effect. Airtonics Health operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics, serving healthcare providers and patients.
Strategic signal
In May 2020, ITP-System announced its partnership in an international research project focused on COVID-19 therapy using nanosilver. This collaboration signals early validation for Airtonics Health's core technology and its potential relevance in addressing global health crises, indicating a strategic focus on collaborative research and development to advance its therapeutic solutions.
Company Intelligence Q&A
- What is Airtonics Health's primary focus?
- Airtonics Health is focused on developing a minimally invasive method to inactivate the SARS-CoV-2 coronavirus at an early stage of infection, utilizing nanosilver with specific physicochemical parameters.
- Who founded Airtonics Health?
- Airtonics Health was founded by Oron Zachar in July 2020.
- What is Airtonics Health's current operational status?
- Airtonics Health is currently Non Active, having ceased to operate in August 2025.
- What was a key partnership for Airtonics Health?
- In May 2020, ITP-System announced its partnership in an international research project on COVID-19 therapy using nanosilver, which aligns with Airtonics Health's core technology.
- In which sector does Airtonics Health primarily operate?
- Airtonics Health operates primarily in the Health Tech & Life Sciences sector, specifically within Medical Devices and Medical Treatment & Therapeutics.